Rapid T cell-based identification of human tumor tissue antigens by automated two-dimensional protein fractionation

Journal of Clinical Investigation

Volumn 120, Issue 6, 2010, Pages 2230-2242

  Beckhove, Philipp ^a   Warta, Rolf ^b   Lemke, Britt ^b   Stoycheva, Diana ^b   Momburg, Frank ^a   Schnölzer, Martina ^a   Warnken, Uwe ^a   Schmitz Winnenthal, Hubertus ^b   Ahmadi, Rezvan ^b   Dyckhoff, Gerhard ^b   Bucur, Mariana ^a   Jünger, Simone ^a   Schueler, Thomas ^a,c   Lennerz, Volker ^d   Woelfel, Thomas ^d   Unterberg, Andreas ^b   Herold Mende, Christel ^b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c HUMBOLDT UNIVERSITY   (Germany)

^d UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN B; EPIDERMAL GROWTH FACTOR RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MUCIN 1; PREALBUMIN;

ARTICLE; BRAIN TUMOR; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHROMATOGRAPHY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGENICITY; LYMPHOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS;

ANIMALS; ANTIGENS; ANTIGENS, NEOPLASM; CD4-POSITIVE T-LYMPHOCYTES; CROSS-PRIMING; HLA ANTIGENS; HUMANS; IMMUNOTHERAPY; MICE; MICE, INBRED C57BL; NEOPLASMS; PEPTIDES; PROTEINS; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 77953190123     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI37646     Document Type: Article

References (48)

1. Lennerz V, et al. The response of autologous T cells to a human melanoma is dominated by mutated neoantigens. Proc Natl Acad Sci U S A. 2005; 102(44):16013-16018. (Pubitemid 41552859)
2. Sommerfeldt N, Schutz F, Sohn C, Forster J, Schirrmacher V, Beckhove P. The shaping of a polyvalent and highly individual T-cell repertoire in the bone marrow of breast cancer patients. Cancer Res. 2006;66(16):8258-8265. (Pubitemid 44299195)
3. Weinschenk T, et al. Integrated functional genomics approach for the design of patient-individual antitumor vaccines. Cancer Res. 2002;62(20):5818-5827. (Pubitemid 35204741)
4. Celis E, et al. Identification of potential CTL epitopes of tumor-associated antigen MAGE-1 for five common HLA-A alleles. Mol Immunol. 1994; 31(18):1423-1430. (Pubitemid 24381799)
5. Cox AL, et al. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science. 1994;264(5159):716-719.
6. Kramer BF, et al. MAGED4-expression in renal cell carcinoma and identification of an HLA-A*25-restricted MHC class I ligand from solid tumor tissue. Cancer Biol Ther. 2005;4(9):943-948.
7. Ramakrishna V, et al. Naturally occurring peptides associated with HLA-A2 in ovarian cancer cell lines identified by mass spectrometry are targets of HLAA2-restricted cytotoxic T cells. Int Immunol. 2003; 15(6):751-763.
8. Schirle M, et al. Identification of tumor-associated MHC class I ligands by a novel T cell-independent approach. Eur J Immunol. 2000;30(8):2216-2225. (Pubitemid 30655761)
9. Sahin U, et al. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci U S A. 1995;92(25):11810-11813. (Pubitemid 26014201)
10. Sheng S, Chen D, Van Eyk JE. Multidimensional liquid chromatography separation of intact proteins by chromatographic focusing and reversed phase of the human serum proteome: optimization and protein database. Mol Cell Proteomics. 2006; 5(1):26-34. (Pubitemid 43169337)
11. Soldi M, et al. Proteome profile of human urine with two-dimensional liquid phase fractionation. Proteomics. 2005;5(10):2641-2647. (Pubitemid 40966491)
12. Billecke C, et al. Analysis of glioma cell platinum response by metacomparison of two-dimensional chromatographic proteome profiles. Mol Cell Proteomics. 2006;5(1):35-42. (Pubitemid 43169338)
13. Gunther NW, Nunez A, Fortis L, Solaiman DK. Proteomic based investigation of rhamnolipid production by Pseudomonas chlororaphis strain NRRL B-30761. J Ind Microbiol Biotechnol. 2006; 33(11):914-920. (Pubitemid 44526882)
14. Lee HJ, Kwon MS, Lee EY, Cho SY, Paik YK. Establishment of a PF2D-MS/MS platform for rapid profiling and semiquantitative analysis of membrane protein biomarkers. Proteomics. 2008;8(11):2168-2177.
15. Ruelle V, et al. An immuno-PF2D-MS/MS proteomic approach for bacterial antigenic characterization: to Bacillus and beyond. J Proteome Res. 2007; 6(6):2168-2175. (Pubitemid 46985103)
16. Schabacker DS, Stefanovska I, Gavin I, Pedrak C, Chandler DP. Protein array staining methods for undefined protein content, manufacturing quality control, and performance validation. Anal Biochem. 2006;359(1):84-93. (Pubitemid 44693521)
17. Girling A, Bartkova J, Burchell J, Gendler S, Gillett C, Taylor-Papadimitriou J. A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM-3 is selectively exposed in a range of primary carcinomas. Int J Cancer. 1989; 43(6):1072-1076.
18. Muller-Berghaus J, et al. Melanoma-reactive T cells in the bone marrow of melanoma patients: association with disease stage and disease duration. Cancer Res. 2006;66(12):5997-6001.
19. Neninger E, et al. Combining an EGF-based cancer vaccine with chemotherapy in advanced nonsmall cell lung cancer. J Immunother. 2009;32(1):92-99.
20. Andrade Filho PA, Lopez-Albaitero A, Gooding W, Ferris RL. Novel immunogenic HLA-A*0201-restricted epidermal growth factor receptor-specific T-cell epitope in head and neck cancer patients. J Immunother. 2010;33(1):83-91.
21. Cheever MA, et al. The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research. Clin Cancer Res. 2009;15(17):5323-5337.
22. Novellino L, Castelli C, Parmiani G. A listing of human tumor antigens recognized by T cells: March 2004 update. Cancer Immunol Immunother. 2005;54(3):187-207.
23. Bonertz A, et al. Antigen-specific Tregs control T cell responses against a limited repertoire of tumor antigens in patients with colorectal carcinoma. J Clin Invest. 2009;119(11):3311-3321.
24. Keller BO, Sui J, Young AB, Whittal RM. Interferences and contaminants encountered in modern mass spectrometry. Anal Chim Acta. 2008;627(1):71-81.
25. Rammensee H, Bachmann J, Emmerich NP, Bachor OA, Stevanovic S. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics. 1999;50(3-4):213-219.
26. Koch C, Jensen SS, Oster A, Houen G. A comparison of the immunogenicity of the native and denatured forms of a protein. APMIS. 1996;104(2):115-125.
27. Schirmbeck R, Bohm W, Melber K, Reimann J. Processing of exogenous heat-aggregated (denatured) and particulate (native) hepatitis B surface antigen for class I-restricted epitope presentation. J Immunol. 1995;155(10):4676-4684.
28. Schirmbeck R, Bohm W, Reimann J. Injection of detergent-denatured ovalbumin primes murine class I-restricted cytotoxic T cells in vivo. Eur J Immunol. 1994;24(9):2068-2072.
29. Zinkernagel RM, Bachmann MF, Kundig TM, Oehen S, Pirchet H, Hengartner H. On immunological memory. Annu Rev Immunol. 1996;14:333-367.
30. Hou X, Aguilar M, Small D. Transthyretin and familial amyloidotic polyneuropathy. Recent progress in understanding the molecular mechanism of neurodegeneration. FEBS J. 2007;274(7):1637-1650.
31. Irace G, Edelhoch H. Thyroxine-induced conformational changes in prealbumin. Biochemistry. 1978;17(26):5729-5733.
32. Peterson PA. Studies on the interaction between prealbumin, retinol-binding protein, and vitamin A. J Biol Chem. 1971;246(1):44-49.
33. Shmueli O, et al. GeneNote: whole genome expression profiles in normal human tissues. C R Biol. 2003;326(10-11):1067-1072.
34. Roberts D, et al. Decreased expression of retinol-binding proteins is associated with malignant transformation of the ovarian surface epithelium. DNA Cell Biol. 2002;21(1):11-19.
35. van Bennekum AM, Wei S, Gamble MV, Vogel S. Biochemical basis for depressed serum retinol levels in transthyretin-deficient mice. J Biol Chem. 2001;276(2):1107-1113.
36. Marchi N, Mazzone P, Fazio V, Mekhail T, Masaryk T, Janigro D. ProApolipoprotein A1: a serum marker of brain metastases in lung cancer patients. Cancer. 2008;112(6):1313-1324.
37. Park CK, Jung JH, Park SH, Jung HW, Cho BK. Multifarious proteomic signatures and regional heterogeneity in glioblastomas. J Neurooncol. 2009; 94(1):31-39.
38. El-Rifai W, et al. Gastric cancers overexpress S100A calcium-binding proteins. Cancer Res. 2002; 62(23):6823-6826. (Pubitemid 35424067)
39. Seth A, Kitching R, Landberg G, Xu J, Zubovits J, Burger A. Gene expression profiling of ductal carcinomas in situ and invasive breast tumors. Anticancer Res. 2003;23(3A):2043-2051.
40. Shen J, Person M, Zhu J, Abbruzzese J, Li D. Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry. Cancer Res. 2004;64(24):9018-9026.
41. Cross SS, Hamdy FC, Deloulme JC, Rehman I. Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers. Histopathology. 2005;46(3):256-269. (Pubitemid 40343172)
42. Newton RA, Hogg N. The human S100 protein MRP-14 is a novel activator of the {beta}2 integrin Mac-1 on neutrophils. J Immunol. 1998;160(3):1427-1435. (Pubitemid 28093444)
43. Yong H, Moon A. Roles of calcium-binding proteins, S100A8 and S100A9, in invasive phenotype of human gastric cancer cells. Arch Pharm Res. 2007;30(1):75-81.
44. Herold-Mende C, et al. Expression and functional significance of vascular endothelial growth factor receptors in human tumor cells. Lab Invest. 1999; 79(12):1573-1582. (Pubitemid 30013922)
45. Dictus C, Tronnier V, Unterberg A, Herold-Mende C. Comparative analysis of in vitro conditions for rat adult neural progenitor cells. J Neurosci Methods. 2007; 161(2):250-258. (Pubitemid 46466951)
46. Choi C, et al. Enrichment of functional CD8 memory T cells specific for MUC1 in bone marrow of patients with multiple myeloma. Blood. 2005; 105(5):2132-2134. (Pubitemid 40731802)
47. Feuerer M, et al. Therapy of human tumors in NOD/SCID mice with patient-derived reactivated memory T cells from bone marrow. Nat Med. 2001; 7(4):452-458. (Pubitemid 32298548)
48. Heinold A, Bauer M, Scherer S, Opelz G, Tran TH. Characterization of a new HLA-B allele, HLAB* 5312, and re-evaluation of the published sequences of the untranslated regions of HLA-B*35 and HLA-B*53. Tissue Antigens. 2007;70(4):319-323.